In Situ High-Resolution Imaging of Live Treponema pallidum Using Catalyst-Free Bioorthogonal Strategy

Jialin Huang , Judun Zheng , Xu Chen , Weiqiang Lin , Minghai Zhao , Qiulin Xie , Zeyu Liu , Dong Wang , Ben Zhong Tang , Yuhui Liao

Aggregate ›› 2025, Vol. 6 ›› Issue (11) : e70154

PDF
Aggregate ›› 2025, Vol. 6 ›› Issue (11) :e70154 DOI: 10.1002/agt2.70154
RESEARCH ARTICLE
In Situ High-Resolution Imaging of Live Treponema pallidum Using Catalyst-Free Bioorthogonal Strategy
Author information +
History +
PDF

Abstract

Treponema pallidum (T. pallidum) causes syphilis, a sexually transmitted disease that leads to multi-organ complications and even death. The lack of technology for tracing live T. pallidum greatly impedes understanding of the pathogenesis of T. pallidum. Herein, we firstly designed and developed an in situ high-resolution imaging strategy to trace live T. pallidum using catalyst-free bioorthogonal labeling with aggregation-induced emission luminogens (AIEgens). An activated alkyne-containing AIEgen, 5-(4-(diphenylamino) phenylthiophene-2-ynylidene) ketone (named TPA-TA), was directly reacted with the proteins of T. pallidum through metal-free click chemistry, without affecting T. pallidum’s activity. Specially, TPA-TA enables high-resolution imaging of live T. pallidum with low background. Both whole phcagocytosis of T. pallidum by THP-1 cells and dissemination in lesions could be monitored in real time, which helped clarify the interaction between the immune clearance and escape of T. pallidum. In conclusion, this catalyst-free bioorthogonal labeling strategy enriches the toolkit for exploring and understanding syphilis-related pathologies.

Keywords

aggregation-induced emission / catalyst-free bioorthogonal reaction / phagocytosis / real-time monitoring / Treponema pallidum

Cite this article

Download citation ▾
Jialin Huang, Judun Zheng, Xu Chen, Weiqiang Lin, Minghai Zhao, Qiulin Xie, Zeyu Liu, Dong Wang, Ben Zhong Tang, Yuhui Liao. In Situ High-Resolution Imaging of Live Treponema pallidum Using Catalyst-Free Bioorthogonal Strategy. Aggregate, 2025, 6(11): e70154 DOI:10.1002/agt2.70154

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

R. W. Peeling, D. Mabey, X.-S. Chen, and P. J. S. Garcia, “Syphilis,” The Lancet 402 (2023): 336–346.

[2]

M. Tsuboi, J. Evans, E. P. Davies, et al., “Prevalence of Syphilis Among Men Who Have Sex With Men: A Global Systematic Review and Meta-Analysis From 2000–20,” Lancet Global Health 9 (2021): e1110–e1118.

[3]

“Syphilis,” World Health Organization, published August 7, 2024, https://www.who.int/news-room/fact-sheets/detail/syphilis.

[4]

R. E. LaFond and S. A. Lukehart, “Biological Basis for Syphilis,” Clinical Microbiology Reviews 19 (2006): 29–49.

[5]

J. Li, J. Ma, M. Liu, et al., “Large-Scale Proteome Profiling Identifies Biomarkers Associated With Suspected Neurosyphilis Diagnosis,” Advancement of Science 11 (2024): e2307744.

[6]

J. D. Radolf, R. K. Deka, A. Anand, D. Šmajs, M. V. Norgard, and X. F. Yang, “Treponema pallidum, the Syphilis Spirochete: Making a Living as a Stealth Pathogen,” Nature Reviews Microbiology 14 (2016): 744–759.

[7]

J. D. Radolf and S. A. Lukehart, Pathogenic Treponema: Molecular and Cellular Biology (Caister Academic Press, 2006).

[8]

W. Chen, H. Luo, L. Zeng, et al., “A Suite of PCR-LwCas13a Assays for Detection and Genotyping of Treponema pallidum in Clinical Samples,” Nature Communications 13 (2022): 4671.

[9]

A. M. Haynes, L. Giacani, M. V. Mayans, et al., “Efficacy of Linezolid on Treponema pallidum, the Syphilis Agent: A Preclinical Study,” EBioMedicine 65 (2021): 103281.

[10]

E. S. Theel, S. S. Katz, and A. Pillay, “Molecular and Direct Detection Tests for Treponema pallidum Subspecies Pallidum: A Review of the Literature, 1964–2017,” Clinical Infectious Diseases 71 (2020): S4–S12.

[11]

K. V. Lithgow, R. Hof, C. Wetherell, D. Phillips, S. Houston, and C. E. Cameron, “A Defined Syphilis Vaccine Candidate Inhibits Dissemination of Treponema pallidum Subspecies pallidum,” Nature Communications 8 (2017): 14273.

[12]

Q.-Y. Xu, X.-Q. Zheng, W.-M. Ye, et al., “Platelet-Derived Major Histocompatibility Complex Class I Coating on Treponema pallidum Attenuates Natural Killer Cell Lethality,” Virulence 15 (2024): 2350892.

[13]

B. Church, E. Wall, J. R. Webb, and C. E. Cameron, “Interaction of Treponema pallidum, the Syphilis Spirochete, With Human Platelets,” PLoS ONE 14 (2019): e0210902.

[14]

Y. Zhang, Y. Zhang, W. Hu, et al., “Development of an Automated Processing Platform Based on Luciferase Fused TPP17 to Detect Specific Treponema pallidum Antibody in Clinical Serum With High Sensitivity and Rapidity,” International Journal of Biological Macromolecules 283 (2024): 137530.

[15]

H. Chen, M.-L. Tong, L.-L. Liu, L.-R. Lin, and T.-C. Yang, “The Whole Process of Macrophage–Treponema pallidum Interactions: Opsonic Phagocytosis, Nonopsonic Phagocytosis and Active Invasion,” International Immunopharmacology 107 (2022): 108657.

[16]

Y.-P. Hsu, G. Booher, A. Egan, W. Vollmer, and M. S. VanNieuwenhze, “d-Amino Acid Derivatives as in situ Probes for Visualizing Bacterial Peptidoglycan Biosynthesis,” Accounts of Chemical Research 52 (2019): 2713–2722.

[17]

F. Hu, G. Qi, Kenry, et al., “Visualization and in situ Ablation of Intracellular Bacterial Pathogens Through Metabolic Labeling,” Angewandte Chemie International Edition 59 (2020): 9288–9292.

[18]

Z. Liu, X. Zhang, S. Xiong, et al., “Endothelial Dysfunction of Syphilis: Pathogenesis,” Journal of the European Academy of Dermatology and Venereology 38 (2024): 1478–1490.

[19]

L. Zhang, B. Huang, J. Jin, Y. Li, and N. J. B. Gu, “Advances in Nanoprobes-Based Immunoassays,” BMEMat 2 (2024): e12057.

[20]

W. Shao, F. Zhao, J. Xue, and L. J. B. Huang, “NIR-II Absorbing Organic Nanoagents for Photoacoustic Imaging and Photothermal Therapy,” BMEMat 1 (2023): e12009.

[21]

S. Guo, H. Tang, Y. Zhang, Z. Wang, and S. C. J. B. Tan, “Recent Advances in Biomimetic Aggregation-Induced Emission Photosensitizers for Photodynamic Therapy and Immunotherapy,” BMEMat 2 (2024): e12076.

[22]

X. Meng, X. Pang, K. Zhang, et al., “Recent Advances in Near-Infrared-II Fluorescence Imaging for Deep-Tissue Molecular Analysis and Cancer Diagnosis,” Small 18 (2022): e2202035.

[23]

X. Wu, W. Shi, X. Li, and H. Ma, “A Strategy for Specific Fluorescence Imaging of Monoamine Oxidase A in Living Cells,” Angewandte Chemie International Edition 56 (2017): 15319–15323.

[24]

L. Wang, R. Chen, G. Han, et al., “Super-Resolution Analyzing Spatial Organization of Lysosomes With an Organic Fluorescent Probe,” Exploration 2 (2022): 20210215.

[25]

X. Jiang, Q. Zhou, B. Du, et al., “Noninvasive Monitoring of Hepatic Glutathione Depletion Through Fluorescence Imaging and Blood Testing,” Science Advances 7 (2021): eabd9847.

[26]

W. Lin, J. Huang, S. Guo, et al., “A Tunable Fluorescent Probe for Superoxide Anion Detection During Inflammation Caused by Treponema pallidum,” Journal of Materials Chemistry B 11 (2023): 4523–4528.

[27]

Y. Jin, D. Li, X. Zheng, et al., “A Novel Activatable Nanoradiosensitizer for Second Near-Infrared Fluorescence Imaging-Guided Safe-Dose Synergetic Chemo-Radiotherapy of Rheumatoid Arthritis,” Advancement of Science 11 (2024): e2308905.

[28]

B. Situ, S. Chen, E. Zhao, et al., “Real-Time Imaging of Cell Behaviors in Living Organisms by a Mitochondria-Targeting AIE Fluorogen,” Advanced Functional Materials 26 (2016): 7132–7138.

[29]

Y. Bai, E. Y. Yu, Y. Liu, et al., “Molecular Engineering of AIE Photosensitizers for Inactivation of Rabies Virus,” Small 19 (2023): 2303542.

[30]

X. He, Y. Yang, Y. Guo, et al., “Phage-Guided Targeting, Discriminative Imaging, and Synergistic Killing of Bacteria by AIE Bioconjugates,” Journal of the American Chemical Society 142 (2020): 3959–3969.

[31]

X. Lin, W. Li, Y. Wen, L. Su, and X. Zhang, “Aggregation-Induced Emission (AIE)-Based Nanocomposites for Intracellular Biological Process Monitoring and Photodynamic Therapy,” Biomaterials 287 (2022): 121603.

[32]

Y. Hong, J. W. Y. Lam, and B. Z. Tang, “Aggregation-Induced Emission,” Chemical Society Reviews 40 (2011): 5361.

[33]

N. Song, Z. Zhang, P. Liu, et al., “Nanomaterials With Supramolecular Assembly Based on AIE Luminogens for Theranostic Applications,” Advanced Materials 32 (2020): 2004208.

[34]

Y. Duo, G. Luo, W. Zhang, et al., “Noncancerous Disease-Targeting AIEgens,” Chemical Society Reviews 52 (2023): 1024–1067.

[35]

J. Li, J. Wang, H. Li, N. Song, D. Wang, and B. Z. Tang, “Supramolecular Materials Based on AIE Luminogens (AIEgens): Construction and Applications,” Chemical Society Reviews 49 (2020): 1144–1172.

[36]

B. Li, W. Wang, L. Zhao, et al., “Photothermal Therapy of Tuberculosis Using Targeting Pre-Activated Macrophage Membrane-Coated Nanoparticles,” Nature Nanotechnology 19 (2024): 834–845.

[37]

W. Z. Yuan, P. Lu, S. Chen, et al., “Changing the Behavior of Chromophores From Aggregation-Caused Quenching to Aggregation-Induced Emission: Development of Highly Efficient Light Emitters in the Solid State,” Advanced Materials 22 (2010): 2159–2163.

[38]

G. Dai, Y. Luo, M. Liao, et al., “A Cytoderm Metabolic Labeling AIEgen for Rapid Detection and Intracellular Ablation of Mycobacterium Tuberculosis,” Cell Reports Physical Science 4 (2023): 101238.

[39]

D. Mao, F. Hu, Kenry, et al., “Metal–Organic-Framework-Assisted In Vivo Bacterial Metabolic Labeling and Precise Antibacterial Therapy,” Advanced Materials 30 (2018): 1706831.

[40]

K. S. Rakesh, M. F. Santos, C. Herndon, et al., “Detection by Super-Resolution Microscopy of Viral Proteins Inside Bloodborne Extracellular Vesicles,” Extracellular Vesicles and Circulating Nucleic Acids 4 (2023): 557–567.

[41]

R. Zhang, J. Zheng, and T. Zhang, “In Vivo Selective Imaging of Metabolic Glycosylation With a Tetrazine-Modified Upconversion Nanoprobe,” RSC Advances 10 (2020): 15990–15996.

[42]

D. G. Edmondson, B. Hu, and S. J. Norris, “Long-Term In Vitro Culture of the Syphilis Spirochete Treponema pallidum subsp. pallidum,” mBio 9 (2018): 01153–01118.

[43]

L. C. Tantalo, A. F. Luetkemeyer, N. A. P. Lieberman, et al., “In Vitro Exposure of Treponema pallidum to Subbactericidal Doxycycline Did Not Induce Resistance: Implications for Doxycycline Postexposure Prophylaxis,” Journal of Infectious Diseases 231 (2025): 729–733.

[44]

X. Hu, X. Zhao, B. He, et al., “A Simple Approach to Bioconjugation at Diverse Levels: Metal-Free Click Reactions of Activated Alkynes With Native Groups of Biotargets Without Prefunctionalization,” Research 2018 (2018): 3152870.

[45]

D. Wang and B. Z. Tang, “Aggregation-Induced Emission Luminogens for Activity-Based Sensing,” Accounts of Chemical Research 52 (2019): 2559–2570.

[46]

World Health Organization. Interpretation of semen examinationresults. In: WHO laboratory manual for the examination and processing of human semen. 6th ed: Geneva: World HealthOrganization;2021, https://www.who.int/publications/i/item/9789240030787.

[47]

H. Konishi, Z. Yoshii, and D. Cox, “Electron Microscopy of Treponema pallidum (Nichols) Cultivated in Tissue Cultures of Sf1Ep Cells,” Infection and Immunity 53 (1986): 32–37.

[48]

W. Li, L. Xie, Q.-L. Li, et al., “Treponema pallidum Membrane Protein Tp47 Promotes Angiogenesis Through ROS-Induced Autophagy,” Journal of the European Academy of Dermatology and Venereology 37 (2023): 558–572.

[49]

K. V. Lithgow, E. Tsao, E. Schovanek, A. Gomez, L. A. Swayne, and C. E. Cameron, “Treponema pallidum Disrupts VE-Cadherin Intercellular Junctions and Traverses Endothelial Barriers Using a Cholesterol-Dependent Mechanism,” Frontiers in Microbiology 12 (2021): 691731.

[50]

B. Kelly and L. A. O'neill, “Metabolic Reprogramming in Macrophages and Dendritic Cells in Innate Immunity,” Cell Research 25 (2015): 771–784.

[51]

L.-R. Lin, Z.-X. Gao, Y. Lin, et al., “Akt, mTOR and NF-κB Pathway Activation in Treponema pallidum Stimulates M1 Macrophages,” International Immunopharmacology 59 (2018): 181–186.

[52]

S. A. Baker-Zander and S. A. Lukehart, “Macrophage-Mediated Killing of Opsonized Treponema pallidum,” Journal of Infectious Diseases 165 (1992): 69–74.

[53]

K. L. Hawley, A. R. Cruz, S. J. Benjamin, et al., “IFNγ Enhances CD64-Potentiated Phagocytosis of Treponema pallidum Opsonized With Human Syphilitic Serum by Human Macrophages,” Frontiers in Immunology 8 (2017): 1227.

[54]

J. Huang, Y. Jiang, W. Lin, et al., “Virulence and Adhesion of the Treponema pallidum Nichols Strain Simultaneously Decrease in a Continuous-Infection New Zealand White Rabbit Model,” ACS Infectious Diseases 9 (2023): 1221–1231.

[55]

L. E. Pereira, S. S. Katz, Y. Sun, et al., “Successful Isolation of Treponema pallidum Strains From Patients′ Cryopreserved Ulcer Exudate Using the Rabbit Model,” PLoS ONE 15 (2020): e0227769.

[56]

L. C. Tantalo, S. A. Lukehart, and C. M. Marra, “Treponema pallidum Strain-Specific Differences in Neuroinvasion and Clinical Phenotype in a Rabbit Model,” Journal of Infectious Diseases 191 (2005): 75–80.

[57]

S. Xiong, Z. Liu, X. Zhang, et al., “Resurgence of Syphilis: Focusing on Emerging Clinical Strategies and Preclinical Models,” Journal of Translational Medicine 21 (2023): 917.

[58]

Y. Luo, Y. Xie, and Y. Xiao, “Laboratory Diagnostic Tools for Syphilis: Current Status and Future Prospects,” Frontiers in Cellular and Infection Microbiology 10 (2021): 574806.

[59]

X. Chen, T. Bai, R. Hu, et al., “Aroylacetylene-Based Amino-Yne Click Polymerization Toward Nitrogen-Containing Polymers,” Macromolecules 53 (2020): 2516–2525.

RIGHTS & PERMISSIONS

2025 The Author(s). Aggregate published by SCUT, AIEI, and John Wiley & Sons Australia, Ltd.

PDF

3

Accesses

0

Citation

Detail

Sections
Recommended

/